Appointment of Secretarial Auditor
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has appointed M/s Swapnil J Dixit & Associates as its Secretarial Auditor for a five-year term covering FY2025-26 to FY2029-30 (April 1, 2025 to March 31, 2030). Shareholders approved this at the 40th Annual General Meeting held on September 30, 2025, based on the recommendation of the Audit Committee and Board. This is effectively a reappointment of the same firm, whose previous term ended on March 31, 2025, to ensure continued compliance with the Companies Act, 2013 and SEBI LODR Regulation 24(A). The auditor, CS Swapnil J Dixit, heads a peer-reviewed Goa-based firm of company secretaries serving over 200 companies, and is independent of the company's directors.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms the company has met SEBI's mandatory secretarial audit requirements through a known, peer-reviewed firm.